Literature DB >> 18164806

Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo.

Olga V Chumakova1, Anton V Liopo, Valery G Andreev, Inga Cicenaite, B Mark Evers, Shilla Chakrabarty, Todd C Pappas, Rinat O Esenaliev.   

Abstract

The goal of this study was to enhance gene delivery and tumor cell transfection in vivo by using a combination of ultrasonication with complex nanoparticles consisting of two types of nanoparticles: PEI/DNA beta-gal plasmid with highly positive zeta-potential and air-filled poly (lactic-co-glycolic acid) (PLGA) particles (with negative zeta-potential) manufactured in our laboratory. The PLGA/PEI/DNA nanoparticles were a colloid with positive zeta-potential and injected i.v. in nude mice with DU145 human prostate tumors. We found that the combination of PLGA/PEI/DNA nanoparticles with ultrasonication substantially enhanced tumor cell transfection in vivo. The overexpression of beta-gal gene was evaluated histochemically and by Western blot analysis. At least an 8-fold increase of the cell transfection efficacy was obtained in irradiated tumors compared to non-irradiated controls, while little to no cell death was produced by ultrasonication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164806     DOI: 10.1016/j.canlet.2007.11.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  44 in total

Review 1.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Laser nanothermolysis of human leukemia cells using functionalized plasmonic nanoparticles.

Authors:  Anton V Liopo; André Conjusteau; Marina Konopleva; Michael Andreeff; Alexander A Oraevsky
Journal:  Nano Biomed Eng       Date:  2012

3.  Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.

Authors:  Rammohan Devulapally; Taehwa Lee; Aarohi Barghava-Shah; Thillai V Sekar; Kira Foygel; Sunitha V Bachawal; Jürgen K Willmann; Ramasamy Paulmurugan
Journal:  Nanomedicine (Lond)       Date:  2018-05-23       Impact factor: 5.307

4.  Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival.

Authors:  Caitlin W Burke; Eben Alexander; Kelsie Timbie; Alexander L Kilbanov; Richard J Price
Journal:  Mol Ther       Date:  2013-10-31       Impact factor: 11.454

Review 5.  Drug-loaded nano-microcapsules delivery system mediated by ultrasound-targeted microbubble destruction: A promising therapy method.

Authors:  Jing Ma; Lian Fang DU; Ming Chen; Hang Hui Wang; Ling Xi Xing; Li Fang Jing; Yun Hua Li
Journal:  Biomed Rep       Date:  2013-05-21

6.  Tumor-targeted RNA-interference: functional non-viral nanovectors.

Authors:  Xinghua Pan; Rachel Thompson; Xiaojie Meng; Daocheng Wu; Liang Xu
Journal:  Am J Cancer Res       Date:  2011-09-01       Impact factor: 6.166

Review 7.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

8.  Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.

Authors:  Jing DU; Ying Sun; Feng-Hua Li; Lian-Fang DU; You-Rong Duan
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

9.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

10.  New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery.

Authors:  Jian-Ming Lü; Zhengdong Liang; Xiaoxiao Wang; Jianhua Gu; Qizhi Yao; Changyi Chen
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.